127 related articles for article (PubMed ID: 24574323)
1. Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine.
Menzies EL; Hudson SC; Dargan PI; Parkin MC; Wood DM; Kicman AT
Drug Test Anal; 2014 Jun; 6(6):506-15. PubMed ID: 24574323
[TBL] [Abstract][Full Text] [Related]
2. Salting-out-assisted liquid-liquid extraction as a suitable approach for determination of methoxetamine in large sets of tissue samples.
Hajkova K; Jurasek B; Sykora D; Palenicek T; Miksatkova P; Kuchar M
Anal Bioanal Chem; 2016 Feb; 408(4):1171-81. PubMed ID: 26661068
[TBL] [Abstract][Full Text] [Related]
3. Potential of High-Resolution Mass Spectrometry for the Detection of Drugs and Metabolites in Hair: Methoxetamine in a Real Forensic Case.
Matey JM; López-Fernández A; García-Ruiz C; Montalvo G; Moreno MD; Martínez MA
J Anal Toxicol; 2022 Feb; 46(1):e1-e10. PubMed ID: 33104803
[TBL] [Abstract][Full Text] [Related]
4. Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue-Behavioural, pharmacokinetic and metabolic studies in the Wistar rat.
Horsley RR; Lhotkova E; Hajkova K; Jurasek B; Kuchar M; Palenicek T
Brain Res Bull; 2016 Sep; 126(Pt 1):102-110. PubMed ID: 27155360
[TBL] [Abstract][Full Text] [Related]
5. Analysis of anonymous pooled urine from portable urinals in central London confirms the significant use of novel psychoactive substances.
Archer JR; Dargan PI; Hudson S; Wood DM
QJM; 2013 Feb; 106(2):147-52. PubMed ID: 23178933
[TBL] [Abstract][Full Text] [Related]
6. Methoxetamine--a novel recreational drug with potent hallucinogenic properties.
Zawilska JB
Toxicol Lett; 2014 Nov; 230(3):402-7. PubMed ID: 25128700
[TBL] [Abstract][Full Text] [Related]
7. Fatal intoxication with methoxetamine.
Adamowicz P; Zuba D
J Forensic Sci; 2015 Jan; 60 Suppl 1():S264-8. PubMed ID: 25413263
[TBL] [Abstract][Full Text] [Related]
8. Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances.
Archer JR; Dargan PI; Lee HM; Hudson S; Wood DM
Clin Toxicol (Phila); 2014 Mar; 52(3):160-5. PubMed ID: 24506433
[TBL] [Abstract][Full Text] [Related]
9. Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn.
Meyer MR; Bach M; Welter J; Bovens M; Turcant A; Maurer HH
Anal Bioanal Chem; 2013 Jul; 405(19):6307-21. PubMed ID: 23774830
[TBL] [Abstract][Full Text] [Related]
10. Beyond Ketamine and Phencyclidine: Analytically Confirmed Use of Multiple Novel Arylcyclohexylamines.
Thornton S; Lisbon D; Lin T; Gerona R
J Psychoactive Drugs; 2017; 49(4):289-293. PubMed ID: 28590798
[TBL] [Abstract][Full Text] [Related]
11. Dimethocaine, a synthetic cocaine analogue: studies on its in-vivo metabolism and its detectability in urine by means of a rat model and liquid chromatography-linear ion-trap (high-resolution) mass spectrometry.
Meyer MR; Lindauer C; Welter J; Maurer HH
Anal Bioanal Chem; 2014 Mar; 406(7):1845-54. PubMed ID: 24448968
[TBL] [Abstract][Full Text] [Related]
12. A polydrug intoxication involving methoxetamine in a drugs and driving case.
Elian AA; Hackett J
J Forensic Sci; 2014 May; 59(3):854-8. PubMed ID: 24528118
[TBL] [Abstract][Full Text] [Related]
13. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
Möller I; Wintermeyer A; Bender K; Jübner M; Thomas A; Krug O; Schänzer W; Thevis M
Drug Test Anal; 2011 Sep; 3(9):609-20. PubMed ID: 20872894
[TBL] [Abstract][Full Text] [Related]
14. The identification and chemical characterization of a new arylcyclohexylamine, methoxetamine, using a novel Emergency Department toxicosurveillance tool.
Westwell AD; Hutchings A; Caldicott DG
Drug Test Anal; 2013 Mar; 5(3):203-7. PubMed ID: 22733704
[No Abstract] [Full Text] [Related]
15. An Impaired Driver Found to be Under the Influence of Methoxetamine.
Fassette T; Martinez A
J Anal Toxicol; 2016 Oct; 40(8):700-702. PubMed ID: 27339480
[TBL] [Abstract][Full Text] [Related]
16. Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes.
Meyer MR; Bergstrand MP; Helander A; Beck O
Anal Bioanal Chem; 2016 May; 408(13):3571-91. PubMed ID: 27071765
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profiling of deschloro-N-ethyl-ketamine and identification of new target metabolites in urine and hair using human liver microsomes and high-resolution accurate mass spectrometry.
Larabi IA; Zerizer F; Ameline A; Etting I; Joseph D; Kintz P; Alvarez JC
Drug Test Anal; 2021 Jun; 13(6):1108-1117. PubMed ID: 33538127
[TBL] [Abstract][Full Text] [Related]
18. From the street to the laboratory: analytical profiles of methoxetamine, 3-methoxyeticyclidine and 3-methoxyphencyclidine and their determination in three biological matrices.
De Paoli G; Brandt SD; Wallach J; Archer RP; Pounder DJ
J Anal Toxicol; 2013 Jun; 37(5):277-83. PubMed ID: 23552616
[TBL] [Abstract][Full Text] [Related]
19. New potential biomarkers for mesterolone misuse in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry.
Lu J; Fernández-Álvarez M; Yang S; He G; Xu Y; Aguilera R
J Mass Spectrom; 2015 Jan; 50(1):153-9. PubMed ID: 25601687
[TBL] [Abstract][Full Text] [Related]
20. The ketamine analog methoxetamine: a new designer drug to threaten military readiness.
Craig CL; Loeffler GH
Mil Med; 2014 Oct; 179(10):1149-57. PubMed ID: 25269134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
